|Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study|
JJ Eron, B Clotet, J Durant, C Katlama, P Kumar, A Lazzarin, ...
The Journal of infectious diseases 207 (5), 740-748, 2013
|The importance of social networks in their association to drug equipment sharing among injection drug users: a review|
P De, J Cox, JF Boivin, RW Platt, AM Jolly
Addiction 102 (11), 1730-1739, 2007
|Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis|
DHS Tan, MW Hull, D Yoong, C Tremblay, P O’byrne, R Thomas, J Kille, ...
CMAJ 189 (47), E1448-E1458, 2017
|Cohort profile: the Canadian HIV–hepatitis C co-infection cohort study|
MB Klein, S Saeed, H Yang, J Cohen, B Conway, C Cooper, P Côté, ...
International journal of epidemiology 39 (5), 1162-1169, 2010
|Association between food insecurity and HIV viral suppression: a systematic review and meta-analysis|
W Aibibula, J Cox, AM Hamelin, T McLinden, MB Klein, P Brassard
AIDS and Behavior 21, 754-765, 2017
|How generalizable are the results from trials of direct antiviral agents to people coinfected with HIV/HCV in the real world?|
S Saeed, EC Strumpf, SL Walmsley, K Rollet-Kurhajec, N Pick, ...
Clinical Infectious Diseases 62 (7), 919-926, 2016
|Risk factors for hepatitis C virus reinfection after sustained virologic response in patients coinfected with HIV|
J Young, C Rossi, J Gill, S Walmsley, C Cooper, J Cox, ...
Clinical Infectious Diseases 64 (9), 1154-1162, 2017
|Circulating (1→ 3)-β-D-glucan is associated with immune activation during human immunodeficiency virus infection|
V Mehraj, R Ramendra, S Isnard, FP Dupuy, R Ponte, J Chen, I Kema, ...
Clinical Infectious Diseases 70 (2), 232-241, 2020
|Early initiation rather than prolonged duration of antiretroviral therapy in HIV infection contributes to the normalization of CD8 T-cell counts|
W Cao, V Mehraj, B Trottier, JG Baril, R Leblanc, B Lebouche, J Cox, ...
Clinical Infectious Diseases 62 (2), 250-257, 2016
|Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review|
P De, E Roy, JF Boivin, J Cox, C Morissette
Journal of viral hepatitis 15 (4), 279-292, 2008
|Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: A systematic review|
N Kronfli, B Linthwaite, F Kouyoumdjian, MB Klein, B Lebouché, ...
International Journal of Drug Policy 57, 95-103, 2018
|Include them and they will tell you: Learnings from a participatory process with youth|
JAM MacDonald, AJ Gagnon, C Mitchell, G Di Meglio, JE Rennick, J Cox
Qualitative Health Research 21 (8), 1127-1135, 2011
|Disparities in direct acting antivirals uptake in HIV‐hepatitis C co‐infected populations in Canada|
S Saeed, EC Strumpf, EEM Moodie, J Young, R Nitulescu, J Cox, A Wong, ...
Journal of the International AIDS Society 20 (3), e25013, 2017
|Food insecurity and low CD4 count among HIV-infected people: a systematic review and meta-analysis|
W Aibibula, J Cox, AM Hamelin, H Mamiya, MB Klein, P Brassard
AIDS care 28 (12), 1577-1585, 2016
|Asking to listen: towards a youth perspective on sexual health education and needs|
JA MacDonald, AJ Gagnon, C Mitchell, G Di Meglio, JE Rennick, J Cox
Sex Education 11 (4), 443-457, 2011
|HIV and hepatitis C virus coinfection in C anada: challenges and opportunities for reducing preventable morbidity and mortality|
MB Klein, KC Rollet, S Saeed, J Cox, M Potter, J Cohen, B Conway, ...
HIV medicine 14 (1), 10-20, 2013
|Hepatitis C meanings and preventive strategies among street-involved young injection drug users in Montreal|
E Roy, E Nonn, N Haley, J Cox
International Journal of Drug Policy 18 (5), 397-405, 2007
|Cretaceous Viking formation of the western Canada sedimentary basin|
GE Reinson, WJ Warters, J Cox, PR Price, GD Mossop, I Shetsen
Geological atlas of the western Canada sedimentary basin 1, 353-364, 1994
|Food insecurity in HIV-hepatitis C virus co-infected individuals in Canada: the importance of co-morbidities|
J Cox, AM Hamelin, T McLinden, EEM Moodie, A Anema, ...
AIDS and Behavior 21, 792-802, 2017
|Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users|
J Cox, P De, C Morissette, C Tremblay, R Stephenson, R Allard, L Graves, ...
Social Science & Medicine 66 (2), 211-220, 2008